AnaptysBio (ANAB) Q4 2024 Earnings Report
MX:ANAB Q4 2024 EPS Results
- Actual EPS
- -MXN 9.02
- Consensus EPS
- -MXN 20.27
- Beat/Miss
- Beat by +MXN 11.25
- One Year Ago EPS
- -MXN 19.91
MX:ANAB Q4 2024 Revenue Results
- Actual Revenue
- MXN 809.92M
- Expected Revenue
- MXN 146.21M
- Beat/Miss
- Beat by +MXN 663.71M
- YoY Revenue Growth
- +378.77%
Earnings Announcement Details
- Quarter
- Q4 2024
- Date
- 02/27/2025
- Time
- After Close
- Conference Call
- Thursday, February 27, 2025
MX:ANAB Upcoming Earnings
AnaptysBio's next earnings date is estimated for November 10, 2026, based on past reporting schedules.
Q4 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ANAB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 10, 2026 | 2026 (Q3) | -34.57-34.57 | 9.79 | -453.17% (-44.35) | ― |
| Sep 21, 2026 | 2026 (Q2) | -16.78-16.78 | -16.78 | 0.00% (+0.00) | |
| May 12, 2026 | 2026 (Q1) | 6.52-16.02 | -24.1 | 33.52% (+8.08) | |
| Mar 03, 2026 | 2025 (Q4) | -16.7829.74 | -9.02 | 429.79% (+38.76) | |
| Nov 04, 2025 | 2025 (Q3) | -16.029.79 | -14.28 | 168.55% (+24.06) | |
| Aug 06, 2025 | 2025 (Q2) | -9.02-25.19 | -21.42 | -17.63% (-3.78) | |
| May 05, 2025 | 2025 (Q1) | -14.28-24.10 | -20.53 | -17.38% (-3.57) | |
| Feb 27, 2025 | 2024 (Q4) | -20.27-9.02 | -19.91 | 54.72% (+10.90) | |
| Nov 05, 2024 | 2024 (Q3) | -20.63-14.28 | -17.66 | 19.15% (+3.38) | |
| Aug 05, 2024 | 2024 (Q2) | -13.04-21.42 | -18.79 | -14.00% (-2.63) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed